Semaglutide GLP-1 (10mg)
Semaglutide GLP-1 (10mg)
Couldn't load pickup availability
Semaglutide GLP-1 (10mg)
Semaglutide is a synthetic GLP-1 receptor agonist peptide, part of the glucagon-like peptide-1 (GLP-1) family. It has been widely studied in laboratory settings for its interaction with GLP-1 receptors and its stability in experimental models. Semaglutide is supplied as a high-purity research material, making it suitable for controlled scientific investigation into peptide function and receptor activity.
Disclaimer: This peptide is intended for laboratory research use only. It is not approved for human consumption, therapeutic, or diagnostic applications.
- Fast Shipping
99% Purity
- Made in USA
What is Semaglutide (GLP-1)?
GLP-1 is a synthetic peptide corresponding to the naturally occurring incretin hormone. This 30-31 amino acid research compound has been studied for its glucose-dependent mechanisms and gastric regulatory pathways. Scientific research has investigated its potential interactions with insulin secretion, appetite regulation systems, and various organ protection mechanisms in laboratory models.
Chemical Structure of Semaglutide GLP-1
GLP-1 is a synthetic glucagon-like peptide-1 analog with the sequence: HXEGTFTSDVSSYLEGQAAK-OH.steric diacid-EFIAWLVRGRG. This laboratory-synthesized variant demonstrates enhanced stability characteristics for investigating incretin hormone pathways and glucose-dependent signaling mechanisms in experimental protocols. The peptide's synthetic modifications enable detailed study of gastric regulatory pathway interactions in controlled research environments.
Research and Clinical Studies on Semaglutide GLP-1
1. Appetite Regulation Studies: Laboratory investigations have examined GLP-1 S analog's interactions with gastric emptying mechanisms and intestinal motility pathways. Research has documented the peptide's influence on satiety signaling cascades and appetite regulation systems in controlled experimental environments.
2. Glucose Homeostasis Research: Scientific studies have investigated GLP-1 S analog's role in glucose-dependent insulin secretion pathways and pancreatic beta-cell signaling mechanisms. Laboratory analyses have documented the peptide's interactions with glycemic control systems and glucose regulation pathways.
3. Cardiovascular Research Models: Experimental investigations have explored GLP-1 S analog's interactions with cardiovascular protection pathways and cardiac function mechanisms. Studies have documented the peptide's influence on vascular signaling systems and cardiovascular risk factor modulation in research environments.
4. Glycemic Control Research: Laboratory studies have investigated GLP-1 S analog's interactions with insulin secretion mechanisms and glucagon suppression pathways. Research has documented the peptide's influence on glucose-dependent signaling cascades and glycemic stability mechanisms in controlled laboratory conditions.